| Product NDC: | 51808-207 |
| Proprietary Name: | Pentagastrin |
| Non Proprietary Name: | Pentagastrin |
| Active Ingredient(s): | 250 ug/1.6mL & nbsp; Pentagastrin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51808-207 |
| Labeler Name: | AnazaoHealth Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120619 |
| Package NDC: | 51808-207-01 |
| Package Description: | 5 mL in 1 VIAL (51808-207-01) |
| NDC Code | 51808-207-01 |
| Proprietary Name | Pentagastrin |
| Package Description | 5 mL in 1 VIAL (51808-207-01) |
| Product NDC | 51808-207 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pentagastrin |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120619 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | AnazaoHealth Corporation |
| Substance Name | PENTAGASTRIN |
| Strength Number | 250 |
| Strength Unit | ug/1.6mL |
| Pharmaceutical Classes |